Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Quality of Life and Viral Control Effect of AIDS Patients After Long-acting Injection of Cabotegravir and Rilpivirine

NCT07131826 is registered in ClinicalTrials.gov with National Taiwan University Clinical Trial Center as lead sponsor.

NCT NCT07131826
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07131826 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Quality of Life and Viral Control Effect of AIDS Patients After Long-acting Injection of Cabotegravir and Rilpivirine
Lead sponsor
National Taiwan University Clinical Trial Center
Phase
Observational
Overall status
Not yet recruiting
Start date
August 15, 2025
Completion date
December 31, 2026
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aids, cabotegravir, quality of life, rilpivirine, viral control